Literature DB >> 21094986

Platelets as initiators and mediators of inflammation at the vessel wall.

Guanfang Shi1, Craig N Morrell.   

Abstract

Platelets are dynamic cells with activities that extend beyond thrombosis including an important role in initiating and sustaining vascular inflammation. A role for platelets has been described in many physiologic and pathophysiologic processes such as atherosclerosis, stem cell trafficking, tumor metastasis, and arthritis. Platelet activation at sites of an intact inflamed endothelium contributes to vascular inflammation and vascular wall remodeling. Platelets secrete a wide array of preformed and synthesized inflammatory mediators upon activation that can exert significant local and systemic effects. This review will focus on the role of platelet derived mediators in vascular inflammation and vascular wall remodeling.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21094986      PMCID: PMC3068230          DOI: 10.1016/j.thromres.2010.10.019

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  39 in total

1.  Clopidogrel inhibits platelet adhesion and platelet-dependent mitogenesis in vascular smooth muscle cells.

Authors:  Alexander Hermann; Artur Aron Weber; Karsten Schrör
Journal:  Thromb Res       Date:  2002-01-15       Impact factor: 3.944

2.  Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.

Authors:  T E Maione; G S Gray; J Petro; A J Hunt; A L Donner; S I Bauer; H F Carson; R J Sharpe
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

3.  Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes.

Authors:  J C Holt; E M Rabellino; A M Gewirtz; L M Gunkel; B Rucinski; S Niewiarowski
Journal:  Exp Hematol       Date:  1988-05       Impact factor: 3.084

4.  Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.

Authors:  Elisabeth Marcos; Elie Fadel; Olivier Sanchez; Marc Humbert; Philippe Dartevelle; Gerald Simonneau; Michel Hamon; Serge Adnot; Saadia Eddahibi
Journal:  Circ Res       Date:  2004-04-01       Impact factor: 17.367

5.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

Authors:  P Libby; S J Warner; G B Friedman
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

6.  Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.

Authors:  Orina A Belton; Angela Duffy; Sinead Toomey; Desmond J Fitzgerald
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

7.  ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels.

Authors:  Anna-Karin Wihlborg; Lingwei Wang; Oscar Ostberg Braun; Atli Eyjolfsson; Ronny Gustafsson; Tomas Gudbjartsson; David Erlinge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-12       Impact factor: 8.311

8.  Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release.

Authors:  Diego J Walther; Jens-Uwe Peter; Sandra Winter; Markus Höltje; Nils Paulmann; Maik Grohmann; Jakob Vowinckel; Victor Alamo-Bethencourt; Claudia S Wilhelm; Gudrun Ahnert-Hilger; Michael Bader
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

9.  G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling.

Authors:  Gavin E Morris; Carl P Nelson; Diane Everitt; Paul J Brighton; Nicholas B Standen; R A John Challiss; Jonathon M Willets
Journal:  Cardiovasc Res       Date:  2010-08-12       Impact factor: 10.787

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  28 in total

Review 1.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 2.  Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.

Authors:  Alicia García-Culebras; Violeta Durán-Laforet; Carolina Peña-Martínez; Iván Ballesteros; Jesús M Pradillo; Jaime Díaz-Guzmán; Ignacio Lizasoain; María A Moro
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-21       Impact factor: 6.200

3.  Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection.

Authors:  Guanfang Shi; David J Field; Kyung-ae Ko; Sara Ture; Kalyan Srivastava; Scott Levy; M Anna Kowalska; Mortimer Poncz; Deborah J Fowell; Craig N Morrell
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

Review 4.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

5.  Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals.

Authors:  Bongani B Nkambule; Glenda Davison; Hayley Ipp
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

6.  The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro.

Authors:  Shannon G Loelius; Katie L Lannan; Neil Blumberg; Richard P Phipps; Sherry L Spinelli
Journal:  Thromb Res       Date:  2018-07-06       Impact factor: 3.944

Review 7.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

Review 8.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

9.  Platelet factor 4 mediates vascular smooth muscle cell injury responses.

Authors:  Guanfang Shi; David J Field; Xiaochun Long; Deanne Mickelsen; Kyung-ae Ko; Sara Ture; Vyacheslav A Korshunov; Joseph M Miano; Craig N Morrell
Journal:  Blood       Date:  2013-04-08       Impact factor: 22.113

10.  Gut Microbiota-Related Effects of Tanhuo Decoction in Acute Ischemic Stroke.

Authors:  Qian Guo; Xiaoqing Jiang; Can Ni; Linjing Li; Li Chen; Yaqi Wang; Mo Li; Chunhui Wang; Li Gao; Huaiqiu Zhu; Juexian Song
Journal:  Oxid Med Cell Longev       Date:  2021-05-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.